Bridgeway diagnostics mri cost12/26/2023 ![]() There are many other scanning procedures as well that are used to image a specific body part. This study found MRI targeted biopsy to be cost-effective in diagnosing prostate cancer in the biopsy-naïve setting in Singapore.MRI is a one of the scanning techniques that doctors suggest you if they need high precision pictures of the inner section of your cells, tissues, bones or organs. Probabilistic sensitivity analyses confirmed Strategy 1 to be the least costly, and Strategies 2 and 4 being the preferred strategies when WTP thresholds were US$20,000 and US$30,000, respectively. Sensitivity analyses found the ICERs were affected mostly by changes to the annual discounting rate and prevalence of prostate cancer in men referred for first biopsy, ranging between US$15,755 to US$23,022. Strategies involving MRI targeted biopsy in the repeat biopsy setting were dominated. Deterministic base case analyses with sensitivity analyses were performed using costs from the healthcare system perspective and quality-adjusted life years (QALY) gained as the outcome measure to yield incremental cost-effectiveness ratios (ICERs).ĭeterministic base case analyses showed that Strategy 1 (MRI targeted biopsy alone), Strategy 2 (MRI targeted biopsy ➔ systematic biopsy), and Strategy 4 (MRI targeted biopsy ➔ systematic biopsy ➔ saturation biopsy) were cost-effective options at a willingness-to-pay (WTP) threshold of US$20,000, with ICERs ranging from US$18,975 to US$19,458. They comprised MRI targeted biopsy following a positive pre-biopsy multiparametric MRI (mpMRI), systematic biopsy, or saturation biopsy employed in different testing combinations and sequences. The six diagnostic strategies were selected for their relevance to local clinical practice. The starting model population was men with mean age of 65 years referred for a first prostate biopsy due to clinical suspicion of prostate cancer. evaluate the cost-effectiveness of six diagnostic strategies involving magnetic resonance imaging (MRI) targeted biopsy for diagnosing prostate cancer in initial and repeat biopsy settings from the Singapore healthcare system perspective.Ī combined decision tree and Markov model was developed. 11 Agency for Care Effectiveness, Ministry of Health, Singapore, 16 College Road, Singapore, 169854, Singapore.1 Agency for Care Effectiveness, Ministry of Health, Singapore, 16 College Road, Singapore, 169854, Singapore. 10 Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.9 Department of Urology, National University Hospital, Singapore, Singapore.8 Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.7 Urology Service, Ng Teng Fong General Hospital, Singapore, Singapore.6 Department of Urology, Singapore General Hospital, Singapore, Singapore.5 Department of Urology, Changi General Hospital, Singapore, Singapore. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |